Show an ad over header. AMP

I am the FIRST!!!

Forthcoming book, "An Ugly Truth": How Facebook discovered Russian meddling

"Oh f---, how did we miss this?" Facebook CEO Mark Zuckerberg asked, looking around at the somber faces of his top executives, the N.Y. Times' Sheera Frenkel and Cecilia Kang write in their book, "An Ugly Truth: Inside Facebook’s Battle for Domination," out Tuesday.

In an excerpt provided first to Axios, the authors write that the executives met Dec. 9, 2016, for a briefing on what Facebook's security team knew about Russian meddling on the platform during the election won by Donald Trump.


The security team, it turns out, had first spotted Russian activity on the platform in March 2016. But Zuckerberg and COO Sheryl Sandberg were just being told about it nine months later.

  • The eight-page handout for the meeting — written by Alex Stamos, then Facebook's chief security officer — "acknowledged that Facebook was sitting on a trove of information proving that a foreign government had tried to meddle in the U.S. election."

Frenkel and Kang, in a chapter called "Company Over Country," write that "no one else spoke as Zuckerberg and Sandberg drilled their chief security officer":

Why had they been kept in the dark? How aggressive were the Russians? And why, asked a visibly agitated Sandberg, had she not known that Stamos had put together a special team to look at Russian election interference? Did they need to share what Stamos had found with lawmakers immediately, and did the company have a legal obligation beyond that?

What happened: The security team "had uncovered information that no one, including the U.S. government, had previously known," the authors write.

  • "Stamos felt that he had been trying to sound the alarm on Russia for months."
  • Stamos said: "It was well within my remit to investigate foreign activity within the platform. And we had appropriately briefed the people in our reporting chain ... It became clear after that that it wasn’t enough."

At the meeting, "Stamos gave a somber assessment of where they stood, admitting that no one at the company knew the full extent of the Russian election interference," we learn from "An Ugly Truth."

  • "Zuckerberg demanded that the executives get him answers, so they promised to devote their top engineering talent and resources to investigate what Russia had done on the platform."

Facebook spokesperson Dani Lever said in a previous statement to Axios about the book:

  • "There’s no silver bullet to fighting misinformation and disinformation, which is why we take a comprehensive approach which includes removing fake accounts and coordinated networks, connecting people to reliable information, and running an historic, independent fact-checking program." 

Go deeper: Read a N.Y. Times adaptation (subscription).

regular 4 post ff

infinite scroll 4 pff

GoodRx prices IPO at $33 per share, valued at $12.7 billion

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Keep reading...Show less

Fauci says transition delay harmful to public health as COVID-19 cases surge

NIAID Director Anthony Fauci said on CNN's "State of the Union" Sunday that President Trump's refusal to cooperate with President-elect Biden's transition team hurts public health as coronavirus cases surge across the country.

The state of play: As President Trump refuses to concede the election to President-elect Joe Biden, General Services Administration Administrator Emily Murphy has not signed documents declaring Biden the apparent winner, preventing the president-elect's agency review teams from having access to the information they need in order to get to work.

Keep reading...Show less

FDA authorizes Moderna's COVID-19 vaccine for emergency use

The Food and Drug Administration has issued an emergency use authorization (EUA) for Moderna's COVID-19 vaccine, one day after it was endorsed by a panel of independent experts.

Why it matters: The authorization of a second coronavirus vaccine, coming exactly one week after the FDA cleared Pfizer-BioNTech's vaccine for emergency use, marks another milestone on the country’s path to curbing the pandemic and increases access for millions of Americans.

Keep reading...Show less

EU regulator grants conditional approval to Pfizer-BioNTech vaccine

The European Medicines Agency (EMA) on Monday recommended approval for the Pfizer-BioNTech COVID-19 vaccine.

Why it matters: The milestone means the vaccine is just a step away from being distributed to millions of people in the European Union's 27 countries.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;